Illinois 2025-2026 Regular Session

Illinois House Bill HB2929 Latest Draft

Bill / Introduced Version Filed 02/05/2025

                            104TH GENERAL ASSEMBLY
 State of Illinois
 2025 and 2026 HB2929 Introduced , by Rep. La Shawn K. Ford SYNOPSIS AS INTRODUCED: 20 ILCS 301/5-26 new Amends the Substance Use Disorder Act. Requires the Department of Human Services to establish a mechanism to collect research and data regarding overdose prevention sites (OPSs) and prepare a report for the General Assembly within 12 months after the effective date of the amendatory Act. Provides that the report shall contain information on (1) current research on the effectiveness of an OPS as an overdose prevention strategy; (2) OPS best practices for staffing, placement, and activities; and (3) the benefits and challenges of different OPS models - structures and settings. Requires the Department, in collaboration with people with lived experience, to develop a pilot service, subject to available funding, aimed at saving the lives of people who use substances that shall include the establishment of at least one OPS. Requires the pilot OPSs to offer people, who are most likely to use drugs in public, unobserved, high-risk, and unsanitary locations, a safe space to use pre-obtained substances and connect to community supports or other existing treatment and recovery programs, harm reduction services, and health care. Contains provisions concerning certain principles pilot OPSs must abide by; OPS staffing and location requirements; pilot OPS services; and other matters. Permits the Department to approve an entity to operate a pilot program in one or more jurisdictions. Grants criminal and civil immunity to persons who use pilot OPSs services; pilot OPS staff; and any real property owner upon which the OPS site is located or operates. Contains provisions on public awareness outreach; OPS reporting requirements; home rule exemption; and other matters. Effective immediately. LRB104 12092 KTG 22190 b   A BILL FOR 104TH GENERAL ASSEMBLY
 State of Illinois
 2025 and 2026 HB2929 Introduced , by Rep. La Shawn K. Ford SYNOPSIS AS INTRODUCED:  20 ILCS 301/5-26 new 20 ILCS 301/5-26 new  Amends the Substance Use Disorder Act. Requires the Department of Human Services to establish a mechanism to collect research and data regarding overdose prevention sites (OPSs) and prepare a report for the General Assembly within 12 months after the effective date of the amendatory Act. Provides that the report shall contain information on (1) current research on the effectiveness of an OPS as an overdose prevention strategy; (2) OPS best practices for staffing, placement, and activities; and (3) the benefits and challenges of different OPS models - structures and settings. Requires the Department, in collaboration with people with lived experience, to develop a pilot service, subject to available funding, aimed at saving the lives of people who use substances that shall include the establishment of at least one OPS. Requires the pilot OPSs to offer people, who are most likely to use drugs in public, unobserved, high-risk, and unsanitary locations, a safe space to use pre-obtained substances and connect to community supports or other existing treatment and recovery programs, harm reduction services, and health care. Contains provisions concerning certain principles pilot OPSs must abide by; OPS staffing and location requirements; pilot OPS services; and other matters. Permits the Department to approve an entity to operate a pilot program in one or more jurisdictions. Grants criminal and civil immunity to persons who use pilot OPSs services; pilot OPS staff; and any real property owner upon which the OPS site is located or operates. Contains provisions on public awareness outreach; OPS reporting requirements; home rule exemption; and other matters. Effective immediately.  LRB104 12092 KTG 22190 b     LRB104 12092 KTG 22190 b   A BILL FOR
104TH GENERAL ASSEMBLY
 State of Illinois
 2025 and 2026 HB2929 Introduced , by Rep. La Shawn K. Ford SYNOPSIS AS INTRODUCED:
20 ILCS 301/5-26 new 20 ILCS 301/5-26 new
20 ILCS 301/5-26 new
Amends the Substance Use Disorder Act. Requires the Department of Human Services to establish a mechanism to collect research and data regarding overdose prevention sites (OPSs) and prepare a report for the General Assembly within 12 months after the effective date of the amendatory Act. Provides that the report shall contain information on (1) current research on the effectiveness of an OPS as an overdose prevention strategy; (2) OPS best practices for staffing, placement, and activities; and (3) the benefits and challenges of different OPS models - structures and settings. Requires the Department, in collaboration with people with lived experience, to develop a pilot service, subject to available funding, aimed at saving the lives of people who use substances that shall include the establishment of at least one OPS. Requires the pilot OPSs to offer people, who are most likely to use drugs in public, unobserved, high-risk, and unsanitary locations, a safe space to use pre-obtained substances and connect to community supports or other existing treatment and recovery programs, harm reduction services, and health care. Contains provisions concerning certain principles pilot OPSs must abide by; OPS staffing and location requirements; pilot OPS services; and other matters. Permits the Department to approve an entity to operate a pilot program in one or more jurisdictions. Grants criminal and civil immunity to persons who use pilot OPSs services; pilot OPS staff; and any real property owner upon which the OPS site is located or operates. Contains provisions on public awareness outreach; OPS reporting requirements; home rule exemption; and other matters. Effective immediately.
LRB104 12092 KTG 22190 b     LRB104 12092 KTG 22190 b
    LRB104 12092 KTG 22190 b
A BILL FOR
HB2929LRB104 12092 KTG 22190 b   HB2929  LRB104 12092 KTG 22190 b
  HB2929  LRB104 12092 KTG 22190 b
1  AN ACT concerning State government.
2  Be it enacted by the People of the State of Illinois,
3  represented in the General Assembly:
4  Section 5. The Substance Use Disorder Act is amended by
5  adding Section 5-26 as follows:
6  (20 ILCS 301/5-26 new)
7  Sec. 5-26. Harm reduction services.
8  (a) Legislative findings. The General Assembly finds the
9  following:
10  (1) Illinois is experiencing a growing overdose
11  crisis. According to the Centers for Disease Control and
12  Prevention, over 4,000 Illinoisans died from overdoses
13  between January 2021 and January 2022, a 12.6% increase
14  from the previous year. Most of those preventable deaths
15  involved opioids.
16  (2) A significant reason for the increase in deaths is
17  a poisoned drug supply, with illicit fentanyl killing
18  people using street-bought substances. With the increasing
19  use of potent fentanyl in the illicit substance supply in
20  Illinois, more lives will continue to be lost.
21  (3) Nearly all witnessed opioid overdoses are
22  reversible with the provision of oxygen, naloxone, and
23  other emergency care. However, many people use drugs alone

 

104TH GENERAL ASSEMBLY
 State of Illinois
 2025 and 2026 HB2929 Introduced , by Rep. La Shawn K. Ford SYNOPSIS AS INTRODUCED:
20 ILCS 301/5-26 new 20 ILCS 301/5-26 new
20 ILCS 301/5-26 new
Amends the Substance Use Disorder Act. Requires the Department of Human Services to establish a mechanism to collect research and data regarding overdose prevention sites (OPSs) and prepare a report for the General Assembly within 12 months after the effective date of the amendatory Act. Provides that the report shall contain information on (1) current research on the effectiveness of an OPS as an overdose prevention strategy; (2) OPS best practices for staffing, placement, and activities; and (3) the benefits and challenges of different OPS models - structures and settings. Requires the Department, in collaboration with people with lived experience, to develop a pilot service, subject to available funding, aimed at saving the lives of people who use substances that shall include the establishment of at least one OPS. Requires the pilot OPSs to offer people, who are most likely to use drugs in public, unobserved, high-risk, and unsanitary locations, a safe space to use pre-obtained substances and connect to community supports or other existing treatment and recovery programs, harm reduction services, and health care. Contains provisions concerning certain principles pilot OPSs must abide by; OPS staffing and location requirements; pilot OPS services; and other matters. Permits the Department to approve an entity to operate a pilot program in one or more jurisdictions. Grants criminal and civil immunity to persons who use pilot OPSs services; pilot OPS staff; and any real property owner upon which the OPS site is located or operates. Contains provisions on public awareness outreach; OPS reporting requirements; home rule exemption; and other matters. Effective immediately.
LRB104 12092 KTG 22190 b     LRB104 12092 KTG 22190 b
    LRB104 12092 KTG 22190 b
A BILL FOR

 

 

20 ILCS 301/5-26 new



    LRB104 12092 KTG 22190 b

 

 



 

  HB2929  LRB104 12092 KTG 22190 b


HB2929- 2 -LRB104 12092 KTG 22190 b   HB2929 - 2 - LRB104 12092 KTG 22190 b
  HB2929 - 2 - LRB104 12092 KTG 22190 b
1  or use them with people who do not have naloxone and are
2  not trained in overdose response.
3  (4) Overdose prevention sites can save lives. Overdose
4  prevention sites provide individuals with a safe, hygienic
5  space to consume pre-obtained drugs and access to other
6  harm reduction, treatment, recovery, and ancillary support
7  services.
8  (5) The goals of overdose prevention sites are:
9  (A) Saving lives by quickly providing emergency
10  care to persons experiencing an overdose.
11  (B) Reducing the spread of infectious diseases,
12  such as HIV and hepatitis.
13  (C) Reducing public injection of substances and
14  discarded syringes in surrounding areas.
15  (D) Linking those with substance use disorders to
16  behavioral and physical health supports.
17  (b) Definitions. As used in this Section:
18  "Entity" means (i) any community-based organization that
19  provides educational, health, harm reduction, housing, or
20  social services and (ii) any hospital, medical clinic or
21  office, health center, community-based mental health center,
22  or other similar entity that provides medical care.
23  "Harm reduction" refers to a philosophical framework and
24  set of strategies designed to reduce harm and promote dignity
25  and well-being among persons and communities who engage in
26  substance use.

 

 

  HB2929 - 2 - LRB104 12092 KTG 22190 b


HB2929- 3 -LRB104 12092 KTG 22190 b   HB2929 - 3 - LRB104 12092 KTG 22190 b
  HB2929 - 3 - LRB104 12092 KTG 22190 b
1  "Overdose prevention sites" means hygienic locations where
2  individuals may safely consume pre-obtained substances.
3  "Participant" means an individual who seeks to utilize,
4  utilizes, or has utilized services provided at an overdose
5  prevention site established in accordance with this Section.
6  (c) The Department shall establish a mechanism to collect
7  research and data regarding overdose prevention sites (OPSs)
8  and prepare a report for the General Assembly within 12 months
9  after the effective date of this amendatory Act of the 104th
10  General Assembly. The Department may identify collaborators
11  across other Departments and State universities. The report
12  shall contain information on:
13  (1) The current research on the effectiveness of an
14  OPS as an overdose prevention strategy.
15  (2) OPS best practices for staffing, placement, and
16  activities.
17  (3) The benefits and challenges of different OPS
18  models - structures and settings.
19  (d) The Department, in collaboration with people with
20  lived experience, shall develop a pilot service, subject to
21  available funding, aimed at saving the lives of people who use
22  substances that shall include the establishment of at least
23  one OPS. Pilot OPSs shall offer people, who are most likely to
24  use drugs in public, unobserved, high-risk, and unsanitary
25  locations, a safe space to use pre-obtained substances and
26  connect to community supports or other existing treatment and

 

 

  HB2929 - 3 - LRB104 12092 KTG 22190 b


HB2929- 4 -LRB104 12092 KTG 22190 b   HB2929 - 4 - LRB104 12092 KTG 22190 b
  HB2929 - 4 - LRB104 12092 KTG 22190 b
1  recovery programs, harm reduction services, and health care.
2  (e) Pilot OPSs shall abide by the following principles:
3  (1) Nothing About Us Without Us: OPS programs and
4  services shall be formulated with transparency, community
5  involvement, and direct input by people who use
6  substances.
7  (2) Equity: OPS staff and programs shall provide equal
8  support, services, and resources to all participants and
9  ensure accessibility to the greatest extent possible.
10  (3) Harm Reduction: OPS shall prioritize individual
11  dignity and autonomy in decision-making while encouraging
12  people to reduce high-risk behaviors.
13  (4) OPS shall affirm the humanity and dignity of
14  people who use substances and shall be operated in a way
15  that is safe, clean, inclusive, and welcoming to reduce
16  stigma and build trust.
17  (5) OPS shall prioritize relationship-building and
18  trust among staff and participants in order to create safe
19  spaces and provide increased opportunities to connect with
20  additional services that promote health and well-being.
21  (f) Staffing.
22  (1) OPS staff, at a minimum, shall consist of trained
23  peers with lived experience of substance use or overdose,
24  along with other necessary professionals such as community
25  health workers, behavioral health professionals,
26  physicians, nurses, or medical personnel who have been

 

 

  HB2929 - 4 - LRB104 12092 KTG 22190 b


HB2929- 5 -LRB104 12092 KTG 22190 b   HB2929 - 5 - LRB104 12092 KTG 22190 b
  HB2929 - 5 - LRB104 12092 KTG 22190 b
1  trained in overdose responses.
2  (2) A majority of the OPS staff shall include peers.
3  (3) Staffing decisions must ensure that participants
4  utilize the service, feel safe, and are connected to
5  resources.
6  (4) The Department may not prohibit persons with
7  criminal records from frontline, management, or executive
8  positions within entities that operate an OPS.
9  (g) Location. Pilot OPSs shall be established in physical
10  locations with high need determined by rates of overdoses and
11  substance use; and as a natural development or extension of
12  existing harm reduction and outreach programming. Priority
13  shall be given to communities that have the highest number of
14  fatal and non-fatal overdoses as determined by public health
15  data from the Department of Public Health. Pilot OPSs shall
16  specifically target high-risk and socially marginalized drug
17  users in a municipality with a population greater than
18  2,500,000, not to exceed 12 months from implementation.
19  (h) Pilot OPS features. Pilot OPSs shall at a minimum:
20  (1) provide a hygienic space where participants may
21  consume their pre-obtained substances;
22  (2) maintain a supply of naloxone and oxygen on-site,
23  together with the necessary equipment to administer
24  naloxone and oxygen;
25  (3) monitor participants for potential overdose;
26  (4) employ staff trained to administer first aid to

 

 

  HB2929 - 5 - LRB104 12092 KTG 22190 b


HB2929- 6 -LRB104 12092 KTG 22190 b   HB2929 - 6 - LRB104 12092 KTG 22190 b
  HB2929 - 6 - LRB104 12092 KTG 22190 b
1  participants who are experiencing an overdose;
2  (5) provide sterile injection or other substance use
3  supplies, collect used hypodermic needles and syringes,
4  and provide secure hypodermic needle and syringe disposal
5  services in compliance with the Overdose Prevention and
6  Harm Reduction Act and any applicable rules adopted by the
7  Department of Public Health;
8  (6) provide safer smoking and safer snorting kits;
9  (7) provide naloxone;
10  (8) encourage drug checking or the use of fentanyl
11  test strips;
12  (9) provide education on safe consumption practices,
13  the proper disposal of hypodermic needles and syringes,
14  and overdose prevention;
15  (10) provide referrals to substance use disorder and
16  mental health treatment, medication-assisted treatment or
17  recovery, and other services which address social
18  determinants of health which include Housing First
19  programs;
20  (11) offer a quiet and comfortable space for
21  participants to stay safely sheltered and supervised after
22  consuming substances; and
23  (12) train staff members and volunteers to deliver
24  services offered at the overdose prevention site, and
25  maintain an adequate staff of health care professionals or
26  other trained staff or volunteers. Trainings shall be

 

 

  HB2929 - 6 - LRB104 12092 KTG 22190 b


HB2929- 7 -LRB104 12092 KTG 22190 b   HB2929 - 7 - LRB104 12092 KTG 22190 b
  HB2929 - 7 - LRB104 12092 KTG 22190 b
1  conducted and partnered with established harm reduction
2  professionals.
3  (i) Other OPS program design and implementation shall be
4  informed by the target community and the report submitted to
5  the General Assembly.
6  (j) The Department may approve an entity to operate a
7  pilot program in one or more jurisdictions upon satisfaction
8  of the requirements set forth in this Section. The Department
9  shall establish standards for program approval and training.
10  (k) Immunity provided. Notwithstanding the Illinois
11  Controlled Substances Act, the Drug Paraphernalia Control Act,
12  or any other provision of law to the contrary, the following
13  persons shall not be arrested, charged, or prosecuted for any
14  criminal offense or violation of parole, mandatory supervised
15  release, probation, or conditional discharge, or be subject to
16  any civil or administrative penalty, including seizure or
17  forfeiture of assets or real property or disciplinary action
18  by a professional licensing board, or be denied any right or
19  privilege solely for participation or involvement at an
20  overdose prevention site approved by the Department under this
21  Act:
22  (1) any individual who seeks to utilize, utilizes, or
23  has utilized services provided at an overdose prevention
24  site established in accordance with this Section;
25  (2) a staff member or administrator of an overdose
26  prevention site, including a healthcare professional,

 

 

  HB2929 - 7 - LRB104 12092 KTG 22190 b


HB2929- 8 -LRB104 12092 KTG 22190 b   HB2929 - 8 - LRB104 12092 KTG 22190 b
  HB2929 - 8 - LRB104 12092 KTG 22190 b
1  manager, employee, or volunteer; and
2  (3) an individual who owns real property at which an
3  overdose prevention site is located or operates.
4  Notwithstanding any other law, ordinance, or regulation,
5  any entity licensed as an OPS Harm Reduction Services provider
6  may operate an overdose prevention site as authorized by the
7  Department.
8  (l) The Department shall help educate local communities
9  and public and private entities, such as public safety
10  organizations, social service groups, school districts, faith
11  communities, and businesses, about overdose prevention sites
12  and the evidence regarding the benefits of overdose prevention
13  sites.
14  (m) Reporting. An entity operating an overdose prevention
15  site in accordance with this Section shall, within the time
16  frame specified by the Department, submit a report to the
17  Department that shall include:
18  (1) the number of participants who have received or
19  are receiving services at the overdose prevention site;
20  (2) aggregate information regarding the
21  characteristics of those participants reported under
22  paragraph (1);
23  (3) the number of hypodermic needles, syringes, and
24  harm reduction supplies distributed for use on-site;
25  (4) the number of overdoses experienced and the number
26  of overdoses reversed on-site;

 

 

  HB2929 - 8 - LRB104 12092 KTG 22190 b


HB2929- 9 -LRB104 12092 KTG 22190 b   HB2929 - 9 - LRB104 12092 KTG 22190 b
  HB2929 - 9 - LRB104 12092 KTG 22190 b
1  (5) the number of participants directly and formally
2  referred to other services and the type of services.
3  In compiling the report required under this subsection, an
4  entity operating an overdose prevention site shall exclude all
5  personally identifiable information and adhere to all federal
6  regulations concerning the confidentiality of substance use
7  disorder patient records under Part 2, Subchapter A, Chapter
8  1, Title 42 of the Code of Federal Regulations as that Part
9  existed on December 20, 2024.
10  (n) Home rule preemption. A home rule unit may not
11  prohibit the establishment or operation of an overdose
12  prevention site as provided in this Section. This Section is a
13  denial and limitation of home rule powers and functions under
14  subsection (g) of Section 6 of Article VII of the Illinois
15  Constitution.

 

 

  HB2929 - 9 - LRB104 12092 KTG 22190 b